• Biocompatibility Tests (Hacettepe University, Faculty of Pharmacy).

  • Cytotoxicity.

    Irritation.

    Sensitization.

  • Genotoxicity– Mutagenicity (Tübitak MAM).

  • Animal Tests.

  • Clinical Study.

  • Average age of 20 male subjects: 41.50±8.08 (between 30-55). 7 of the subjects suffering advanced protruded disc hernia and 13 subjects of them suffering extruded disc hernia.

  • Average age of 20 female subjects: 42.30±9.20 (between 24-54). 9 of the subject suffering advanced protruded disc hernia and 10 subjects suffering extruded disc hernia . 1 of the subjects suffering both extruded and protruded disc hernia. (Table 1).

  • Average age of 40 placebo subjects: 45.40±5.20 (between 20-54).

  • Pain scores of all subjects determined according to VAS Scale at 0th hour, 24th hour and 48th hour. Disc hernia diagnosis of all subjects confirmed with MRI.

  • Diffusional Patch applied to all subjects. Exact locations of the herniated discs determined according to MRI. For each case, Diffusional Patch applied by centering the line of disk herniation. Strict bed rest of 24 hours ensured for the subjects. Diffusional Patchs removed at the end of 24th hour.

  • Disc Herniation Level

    Total

     

    Extrusion

    Protrusion

    C4-C5

    5

     

    C5-C6

    1

     

    C5-C6/C6-C7

     

    1

    C4-C5/C6-C7

    2

     

    L4-L5

    6

    3

    L5-S1

    9

    9

    L3-L4

     

    1

    L4-L5/L5 S1

    1

    2

     

    Total

     

     

    24

     

    16

    ARTCURE® DP is a standard product and does not feature types or models.

    Style Switcher

    Color Skin